AR004214A1 - Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas - Google Patents

Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas

Info

Publication number
AR004214A1
AR004214A1 ARP960104658A AR10465896A AR004214A1 AR 004214 A1 AR004214 A1 AR 004214A1 AR P960104658 A ARP960104658 A AR P960104658A AR 10465896 A AR10465896 A AR 10465896A AR 004214 A1 AR004214 A1 AR 004214A1
Authority
AR
Argentina
Prior art keywords
ophthalmic
preparation
cure
drops
diseases
Prior art date
Application number
ARP960104658A
Other languages
English (en)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR004214A1 publication Critical patent/AR004214A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención provee una preparación farmacéutica para tratar enfermedades oftalmológicas que contiene, como ingrediente activo, un derivadode carboestirilo o sal del mismo representado por la fórmula general (I), en donde R es unát omo de halógeno. Particularmente la invención provee un agenteefectivo para tratar el síndrome de xeroftalmia (ojo seco).
ARP960104658A 1995-10-12 1996-09-10 Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas AR004214A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26389695 1995-10-12
JP5733796 1996-03-14

Publications (1)

Publication Number Publication Date
AR004214A1 true AR004214A1 (es) 1998-11-04

Family

ID=26398366

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP960104658A AR004214A1 (es) 1995-10-12 1996-09-10 Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
ARP060103704A AR055393A2 (es) 1995-10-12 2006-08-25 Uso de un derivado de carboestirilo para la preparcion de una composicion farmaceutica para tratar enfermedades oftalmologicas
ARP080105747A AR070051A2 (es) 1995-10-12 2008-12-29 Una preparacion farmaceutica para la cura del sindrome de xeroftalmia

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP060103704A AR055393A2 (es) 1995-10-12 2006-08-25 Uso de un derivado de carboestirilo para la preparcion de una composicion farmaceutica para tratar enfermedades oftalmologicas
ARP080105747A AR070051A2 (es) 1995-10-12 2008-12-29 Una preparacion farmaceutica para la cura del sindrome de xeroftalmia

Country Status (16)

Country Link
US (1) US6060486A (es)
EP (1) EP0859615B1 (es)
KR (1) KR100281865B1 (es)
CN (1) CN1132580C (es)
AR (3) AR004214A1 (es)
AT (1) ATE201992T1 (es)
AU (1) AU709734B2 (es)
CA (1) CA2234247C (es)
DE (1) DE69613386T2 (es)
DK (1) DK0859615T3 (es)
ES (1) ES2159043T3 (es)
GR (1) GR3036457T3 (es)
MX (1) MX9802817A (es)
PT (1) PT859615E (es)
TW (1) TW446702B (es)
WO (1) WO1997013515A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506412B2 (en) 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
DE10133870A1 (de) * 2001-07-12 2003-02-06 Chris P Lohmann Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
KR100907407B1 (ko) * 2002-09-28 2009-07-10 주식회사 케이티 대량 메시지 동보 전송을 위한 메시지 예약 및 전송 방법
WO2005011811A1 (en) * 2003-07-30 2005-02-10 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives for accelerating salivation
CN100551378C (zh) * 2003-11-14 2009-10-21 千寿制药株式会社 包含氨基糖苷类抗生素和溴芬酸的水溶液制剂
TWI340650B (en) 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
KR20070061537A (ko) * 2004-08-27 2007-06-13 센주 세이야꾸 가부시키가이샤 건성안 치료용 안약액
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
PL2285413T3 (pl) * 2008-06-19 2013-01-31 Otsuka Pharma Co Ltd Kompozycja farmaceutyczna
WO2012114317A1 (en) 2011-02-25 2012-08-30 Nuformix Limited Novel rebamipide complexes and cocrystals
TW201322982A (zh) * 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
KR101692578B1 (ko) * 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
WO2015168629A1 (en) * 2014-05-02 2015-11-05 Massachusetts Eye And Ear Infirmary Grading corneal fluorescein staining
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR20170039347A (ko) 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
RU2019130955A (ru) * 2017-03-05 2021-04-07 Ресдевко Рисёрч Энд Дивелопмент Ко. Лтд. Глазные капли для лечения раздражения, не вызванного инфекцией
KR102615076B1 (ko) 2021-07-14 2023-12-19 대우제약 주식회사 안정한 레바미피드 점안제의 대용량 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JPH0713138B2 (ja) * 1986-07-30 1995-02-15 保土谷化学工業株式会社 ポリテトラメチレンエ−テルグリコ−ルの製法
KR0180248B1 (ko) * 1991-06-07 1999-03-20 오오쓰까 아끼히꼬 항당뇨병약품
TW227558B (es) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
AU672888B2 (en) * 1993-03-18 1996-10-17 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives as matrix metalloproteinases inhibitors
JP2839847B2 (ja) * 1993-10-21 1998-12-16 大塚製薬株式会社 インターロイキン−８産生抑制剤
KR970704439A (ko) * 1994-08-10 1997-09-06 오쓰카 아키히코 눈의 염증 및/또는 상처의 예방 및 치료 방법(Method of preventing and treating ophthalmic inflammation and/or wound)

Also Published As

Publication number Publication date
CA2234247A1 (en) 1997-04-17
AR070051A2 (es) 2010-03-10
GR3036457T3 (en) 2001-11-30
AU709734B2 (en) 1999-09-02
CA2234247C (en) 2005-05-10
TW446702B (en) 2001-07-21
WO1997013515A1 (en) 1997-04-17
US6060486A (en) 2000-05-09
DK0859615T3 (da) 2001-09-03
EP0859615A1 (en) 1998-08-26
ATE201992T1 (de) 2001-06-15
CN1202108A (zh) 1998-12-16
EP0859615B1 (en) 2001-06-13
DE69613386T2 (de) 2002-05-23
DE69613386D1 (de) 2001-07-19
PT859615E (pt) 2001-09-28
CN1132580C (zh) 2003-12-31
ES2159043T3 (es) 2001-09-16
KR100281865B1 (ko) 2001-02-15
MX9802817A (es) 1998-09-30
AU7097596A (en) 1997-04-30
AR055393A2 (es) 2007-08-22
KR19990064187A (ko) 1999-07-26

Similar Documents

Publication Publication Date Title
AR004214A1 (es) Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
BR112022000019A2 (pt) Composto da fórmula, composição farmacêutica e método de tratamento de câncer
BR9912098A (pt) Derivado de tiobenzimidazol, composição farmacêutica, e, agente preventivo e/ou terapêutico
AR062046A1 (es) Soluciones oftalmicas
ES2175020T3 (es) Formulacion oftalmica para el uso en la cirugia ocular.
BR0112395A (pt) Derivados de benzotiazol
BRPI0408690A (pt) composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto
JP2010507686A5 (es)
BRPI0416989A (pt) derivados aminopirazole como inibidores gsk-3
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
KR20170126871A (ko) 신규한 요오드포 조성물 및 사용 방법
AR009028A1 (es) Composiciones farmaceuticas, un procedimiento para preparar dichas composiciones y utilizacion de dichas composiciones en el tratamiento deenfermedades oftalmicas y metodos para tratar dichas enfermedades
AR062395A1 (es) Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares
ES2109752T3 (es) Medicamento para tratamiento terapeutico y profilactico de enfermedades causadas por hiperplasia de las celulas de los musculos lisos.
BR9907715A (pt) Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose
BR9712308A (pt) Inibidor de catarata secundária
SE8304616L (sv) Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering
Velpandian et al. Comparative evaluation of possible ocular photochemical toxicity of fluoroquinolones meant for ocular use in experimental models
Quickert A fluorescein-anesthetic solution for applanation tonometry
UY27324A1 (es) Nuevas sales de napsilato i
BR0317289A (pt) Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico
BR0116263A (pt) Derivados de diidroindol e tetraidroquinolina
AR036194A1 (es) Uso de compuestos para la fabricacion de un medicamento que promueven la regeneracion de las neuronas o de las excrecencias neuriticas para el tratamiento de xeroftalmia y para la diminucion de la sensibilidad de la cornea despues de lasik u otras cirugias cuando los nervios corneales estan lesionad
BRPI0413101A (pt) compostos de sulfonamida derivado de benzoxazinona, sua preparação e uso como medicamentos

Legal Events

Date Code Title Description
FC Refusal